DOP073 Efficacy of induction treatment with vedolizumab for patients with Crohn's disease who have experienced tumour necrosis factor antagonist failure or are tumour necrosis factor antagonist naiveWilliam J. Sandborn, Irving H. Fox, Paul Rutgeerts et al.|Journal of Crohn s and Colitis|2014Cited by 5